Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products (U01) Clinical Trials Not Allowed

The Food and Drug Administration (FDA) announces its intention to accept and consider a single source application for award of a Cooperative Agreement to the World Health Organization (WHO) in support of collaboration in regulatory systems strengthening, development of norms and standards, and innovative

research to advance global access to safe and effective biological products that meet international standards.
Related Programs

Food and Drug Administration_Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: Food and Drug Administration

Estimated Funding: $10,000,000


Who's Eligible


Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
Full Announcement of RFA-FD-21-031 on NIH Guide for Grants and Contracts

Additional Information of Eligibility:
The World Health Organization (WHO)

Full Opportunity Web Address:
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-21-031.html

Contact:


Agency Email Description:
gordana.zuber@fda.hhs.gov

Agency Email:


Date Posted:
2021-04-12

Application Due Date:


Archive Date:
2021-08-12


Meticulon, a project of Autism Calgary Association in partnership with the federal government and the Sinneave Family Foundation, operates as a social enterprise that renders high-tech services provided by people with autism, leveraging their natural abilities at requiring attention to detail, repetition, and sequencing.






More Federal Domestic Assistance Programs


Alcohol Open Container Requirements | Surveys, Studies, Investigations, Training, Demonstrations, and Special Purpose Grants for Regional  | Development and Coordination of Rural Health Services | PPHF 2012: Community Transformation GrantsSmall Communities Program financed solely by 2012 Public P | State Energy Program |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders